Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

clinicaltrialsPublishedShowing 101–150 of 228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07243626	Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma	recruiting	Phase 2	25	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Apr 24, 2026	clinicaltrials
NCT04332874	A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg	recruiting	Phase 2	30	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 23, 2026